Role of sulfhydryl groups in benzoquinone-induced Ca2+ release by rat liver mitochondria

https://doi.org/10.1016/0003-9861(88)90061-6Get rights and content

Abstract

Incubation of rat liver mitochondria with benzoquinone derivatives in the presence of succinate plus rotenone has been shown to cause NAD(P)H oxidation followed by Ca2+ release. Further investigation revealed: (1) p-Benzoquinone-induced Ca2 release was not initiated by a collapse of the mitochondrial membrane potential. However, Ca2+ release and subsequent Ca2+ cycling caused limited increased membrane permeability. (2) p-Benzoquinone-induced NAD(P)H oxidation and Ca2+ release were prevented by isocitrate, 3-hydroxybutyrate, and glutamate but not by pyruvate or 2-oxoglutarate. (3) Inhibition of pyruvate and 2-oxoglutarate dehydrogenases by p-benzoquinone was attributed to arylation of the SH groups of the cofactors, CoA and lipoic acid. Isocitrate dehydrogenase was also inhibited by p-benzoquinone, but the cofactors NAD(P)H and Mn2+ protected the enzyme. Glutamate dehydrogenase was not inhibited by p-benzoquinone. (4) Arylation of mitochondrial protein thiols by p-benzoquinone was associated with an inhibition of state 3 respiration, which was attributed to the inactivation of the phosphate translocase. In contrast, state 4 respiration, and the F1 · F0-ATPase and ATPADP translocase activities were not inhibited. It was concluded that inhibition of mitochondrial NAD(P)H dehydrogenases by arylation of critical thiol groups will decrease the NAD(P)+-reducing capacity, and possibly lower the NAD(P)HNAD(P)+ redox status in Favor of Ca2+ release.

References (54)

  • D. Di Monte et al.

    Arch. Biochem. Biophys

    (1984)
  • D. Di Monte et al.

    Arch. Biochem. Biophys

    (1984)
  • G. Bellomo et al.

    Biochem. Pharmacol

    (1987)
  • M.V. Riley et al.

    J. Biol. Chem

    (1964)
  • D.J. Reed

    Biochem. Pharmacol

    (1986)
  • L. Flohé
  • D.R. Pfeiffer et al.

    J. Biol. Chem

    (1979)
  • N.E. Lofrumento et al.

    FEBS Lett

    (1978)
  • A.E. Vercesi

    Biochem. Biophys. Res. Commun

    (1984)
  • E. Chavez et al.

    Arch. Biochem. Biophys

    (1985)
  • E. Chavez et al.

    J. Biol. Chem

    (1988)
  • G.A. Moore et al.

    FEBS Lett

    (1983)
  • M.C. Beatrice et al.

    J. Biol. Chem

    (1984)
  • A.E. Vercesi

    Arch. Biochem. Biophys

    (1987)
  • G.A. Moore et al.

    Arch. Biochem. Biophys

    (1987)
  • L. Rossi et al.

    Arch. Biochem. Biophys

    (1986)
  • A.G. Gornall et al.

    J. Biol. Chem

    (1949)
  • P.C. Jocelyn et al.

    Biochem. Pharmacol

    (1985)
  • J. Sedlak et al.

    Anal. Biochem

    (1968)
  • G.L. Peterson

    Anal. Biochem

    (1977)
  • I.A. Cotgreave et al.

    J. Biochem. Biophys. Methods

    (1986)
  • E. Schmidt
  • S. Baumhüter et al.

    FEBS Lett

    (1982)
  • R.A. Johanson et al.

    Arch. Biochem. Biophys

    (1981)
  • R.F. Colman et al.

    J. Biol. Chem

    (1970)
  • T. Iyanagi et al.

    Biochim. Biophys. Acta

    (1970)
  • R.F. Colman

    J. Biol. Chem

    (1968)
  • Cited by (0)

    2

    Permanent address. Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada M5S 1A1.

    View full text